These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 19523083)

  • 1. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study.
    Guerrero-Romero F; Rodríguez-Morán M; Pérez-Fuentes R; Sánchez-Guillén MC; González-Ortiz M; Martínez-Abundis E; Brito-Zurita O; Madero A; Figueroa B; Revilla-Monsalve C; Flores-Martínez SE; Islas-Andrade S; Rascón-Pacheco RA; Cruz M; Sánchez-Corona J
    Metab Syndr Relat Disord; 2008 Mar; 6(1):15-23. PubMed ID: 18370832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes.
    Rodríguez-Moran M; Guerrero-Romero F; Aradillas-García C; Violante R; Simental-Mendia LE; Monreal-Escalante E; Mendoza Ede L
    Pediatr Diabetes; 2010 Aug; 11(5):331-6. PubMed ID: 19895410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
    Love-Osborne K; Butler N; Gao D; Zeitler P
    Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of impaired fasting glucose and type 2 diabetes in a population-based sample of overweight/obese children in the Middle East.
    Moadab MH; Kelishadi R; Hashemipour M; Amini M; Poursafa P
    Pediatr Diabetes; 2010 Mar; 11(2):101-6. PubMed ID: 19765232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents.
    Maffeis C; Pinelli L; Brambilla P; Banzato C; Valzolgher L; Ulmi D; Di Candia S; Cammarata B; Morandi A
    Obesity (Silver Spring); 2010 Jul; 18(7):1437-42. PubMed ID: 19851301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M; Al-Mamari M; Al-Meeri A
    Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
    Gao W; Dong Y; Nan H; Tuomilehto J; Qiao Q
    Diabetes Res Clin Pract; 2008 Jan; 79(1):151-5. PubMed ID: 17825938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.